×
Todo
Imágenes
Maps
Noticias
takenaka partners
takenaka corporation
cardiovascular effects
astellas pharma
k channel
channel opener
dihydropyridine
pharma intelligence awards japan
pharma inc
japan
lifetime achievement
fujisawa pharmaceutical
Compartir
Esta imagen puede estar sujeta a los derechos de autor.
Facebook
WhatsApp
X
Encontré esta imagen de
ISV_HWD
con Google Imágenes
Correo electrónico
Presiona para copiar el vínculo
Vínculo copiado
Esta imagen puede incluir contenido explícito. El desenfoque de SafeSearch está activado.
Administrar configuración
Ver imagen
Las imágenes pueden estar sujetas a derechos de autor.
Visitar
Compartir
Esta imagen puede incluir contenido explícito. El desenfoque de SafeSearch está activado.
Administrar configuración
Ver imagen
Las imágenes pueden estar sujetas a derechos de autor.
Esta imagen puede incluir contenido explícito. El desenfoque de SafeSearch está activado.
Administrar configuración
Ver imagen
Las imágenes pueden estar sujetas a derechos de autor.
Yamanouchi Pharmaceutical Co. President Toichi Takenaka (R) and ...
www.alamy.com
TOKYO, Japan - Yamanouchi Pharmaceutical Co. President Toichi ...
www.alamy.com
Toichi Takenaka - Director at Healios | The Org
theorg.com
Toichi Takenaka - Director at Healios | The Org
theorg.com
CJU - Legends in Urology
www.canjurol.com
Dr. Toichi Takenaka received Lifetime Achievement Award at Informa ...
www.gifu-pu.ac.jp
Japan's Biopharma Excellence Celebrated At Pharma Intelligence ...
scrip.citeline.com
Yamanouchi, Fujisawa to merge - The Japan Times
www.japantimes.co.jp
Dr. Toichi Takenaka received Lifetime Achievement Award at Informa ...
www.gifu-pu.ac.jp
Toichi Takenaka - Director at Healios | The Org
theorg.com
Toichi Takenaka - Director at Healios | The Org
theorg.com
Toichi Takenaka - Director at Healios | The Org
theorg.com
Toichi Takenaka - Director at Healios | The Org
theorg.com
In Pictures: Japan's Richest
www.forbes.com
Toichi Takenaka - Director at Healios | The Org
theorg.com
Annual Report 2003 (pdf 2.0MB) - Astellas Pharma Inc.
www.yumpu.com
PDF) Cardiovascular effects of YM934, a novel and potent K channel ...
www.researchgate.net
March 31, 2006 Astellas Pharma Inc. ASTELLAS SELLS ALL OUTSTANDING ...
www.astellas.com
Astellas Transfers Its Group Member Company FMS Co., Ltd. to Canon ...
www.astellas.com
PDF) Cardiovascular effect of FR34235, a new dihydropyridine ...
www.researchgate.net
Dopamine DA1 Receptor Agonist Activity of YM435 in the Canine ...
www.sciencedirect.com
PDF) K channel opening effects of YM099 in isolated tissues.
www.researchgate.net
Toichi Takenaka's research works | Tokyo University of Pharmacy ...
www.researchgate.net
Astellas and MerLion Pharmaceuticals announce new drug ...
www.astellas.com
Toichi Takenaka - Director at Healios | The Org
theorg.com
Pharmacological and Pharmacokinetic Characteristics of YM435, a ...
onlinelibrary.wiley.com
In Pictures: Japan's Richest
www.forbes.com
Takenaka Corporation - Wikipedia
en.wikipedia.org
PDF) Pheochromocytoma (PHEO)-harboring New England Deaconess ...
www.researchgate.net
54527-84-3 Nicardipine HCl AKSci C652
aksci.com
Toichi Takenaka's research works | Tokyo University of Pharmacy ...
www.researchgate.net
News - Gifu Pharmaceutical University
www.gifu-pu.ac.jp
Toichi Takenaka's research works | Tokyo University of Pharmacy ...
www.researchgate.net
PDF) Cardiovascular effects of chronic KT3-671 administration, an ...
www.researchgate.net
Toichi Takenaka - Director at Healios | The Org
theorg.com
PDF) Regulation of uterine contractility by cyclic AMP. —Close ...
www.researchgate.net
News release Ferring and Astellas enter a license agreement on ...
www.ferring.com
Pharmacokinetics and Cardiovascular Effects of YM21095, a Novel ...
academic.oup.com
PDF) Endocrine Pharmacology of Reproduction (Report 92): Effects ...
www.researchgate.net
Tamsulosin (Harnal, Flomax, OMNIC) | SpringerLink
link.springer.com
conflictgypsy Publisher Publications - Issuu
issuu.com
Toichi Takenaka's research works | Tokyo University of Pharmacy ...
www.researchgate.net
Tamsulosin (Harnal, Flomax, OMNIC) | SpringerLink
link.springer.com
Kanta Kawai won the Impressive Research Award at The 8th ...
www.gifu-pu.ac.jp
Collaborative Search for Microorganisms in Vietnam November 2 ...
www.astellas.com
ISPE Japan Affiliate Headquarters
www.ispe.gr.jp
Japan's Biopharma Excellence Celebrated At Pharma Intelligence ...
scrip.citeline.com
In Pictures: Japan's Richest
www.forbes.com
In Pictures: Japan's Richest
www.forbes.com
The Causes of Failure: Case Studies of Eight Failed Acquisitions ...
link.springer.com
9+ Joint Marketing Agreement Templates - PDF, Word, Apple Pages ...
www.template.net
PDF) Astellas Drug Discovery Strategy: Focus on Oncology
www.researchgate.net
OFFICIAL GAZETTE
www.yumpu.com
New perspective for the management of M&A process: a merger ...
www.emerald.com
Effect of oq-Adrenoceptor Antagonists on Urinary Bladder Function ...
www.sciencedirect.com
Tamsulosin (Harnal, Flomax, OMNIC) | SpringerLink
link.springer.com
The role of extracellular Ca<Superscript>2+</Superscript ...
link.springer.com
The Business Week In Pictures
www.forbes.com
VASODILATOR AND HYPOTENSIVE EFFECTS OF THE OPTICAL ISOMERS OF ...
www.sciencedirect.com
Toichi Takenaka - Director at Healios | The Org
theorg.com
Tamsulosin (Harnal, Flomax, OMNIC) | SpringerLink
link.springer.com
In Pictures: Japan's Richest
www.forbes.com
Toichi Takenaka - Director at Healios | The Org
theorg.com
Meet the people shaping the future of IP | Managing Intellectual ...
www.managingip.com
BILLIONAIRES 2001 - Forbes
www.yumpu.com
Member Introduction | Forum for Innovative Regenerative Medicine
firm.or.jp
New perspective for the management of M&A process: a merger ...
www.emerald.com
The Causes of Failure: Case Studies of Eight Failed Acquisitions ...
link.springer.com
Meet the people shaping the future of IP | Managing Intellectual ...
www.managingip.com
Frontiers | Dysfunctional Immune Regulation in Autoimmune ...
www.frontiersin.org
TAKENAKA Corporate Report 2017
www.takenaka.co.jp
In Pictures: Japan's Richest
www.forbes.com
January 27, 2006 SNDA FOR A FAST-ACTING POSTPRANDIAL HYPOGLICEMIC ...
www.astellas.com
The Causes of Failure: Case Studies of Eight Failed Acquisitions ...
link.springer.com
OFFICIAL GAZETTE
www.yumpu.com
ˆ ?2021tヲ藪.xlsx
firm.or.jp
New perspective for the management of M&A process: a merger ...
www.emerald.com
Renal effect of YM435, a new dopamine D1 receptor agonist, in ...
www.sciencedirect.com
The Causes of Failure: Case Studies of Eight Failed Acquisitions ...
link.springer.com
News - Gifu Pharmaceutical University
www.gifu-pu.ac.jp
The Business Week In Pictures
www.forbes.com
LEGENDS IN UROLOGY
www.canjurol.com
Comparative Studies of an Orally-active Factor Xa Inhibitor, YM ...
www.thieme-connect.com
Meet the people shaping the future of IP | Managing Intellectual ...
www.managingip.com
WO2005013947A2 - Means and methods for treating a disease which is ...
patents.google.com
The Business Week In Pictures
www.forbes.com
Renal effect of YM435, a new dopamine D1 receptor agonist, in ...
www.sciencedirect.com
Tamsulosin (Harnal, Flomax, OMNIC) | springerprofessional.de
www.springerprofessional.de
The Causes of Failure: Case Studies of Eight Failed Acquisitions ...
link.springer.com
Effect of the Potassium Channel Opener YM934 on the Contractile ...
www.sciencedirect.com
IID 2008 Sponsors - Society for Investigative Dermatology-SID
www.yumpu.com
Yamanouchi Pharmaceutical President Toichi Takenaka and Fujisawa ...
www.gettyimages.ae
Antithrombotic effects of YMâ•'60828, a newly synthesized factor ...
bpspubs.onlinelibrary.wiley.com
EP1088551A1 - Medicinal compositions for treating evacuatory ...
patents.google.com
Pharmacologic characterization of the oxytocin receptor in human ...
bpspubs.onlinelibrary.wiley.com
Tamsulosin (Harnal, Flomax, OMNIC) | SpringerLink
link.springer.com
US20080152640A1 - Means and Methods For Treating a Disease Which ...
patents.google.com
Amino acid signaling is critical to maintain proper posture ...
www.gifu-pu.ac.jp
Licensing Agreement for the Development, Manufacturing and ...
www.astellas.com
The Roles Of Academia, Rare Diseases, And Repurposing In The ...
www.healthaffairs.org